GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Lotus Pharmaceuticals LTUS · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Lotus Pharmaceuticals — daily LTUS Delayed
Market value
$83,689
Last close × shares
Volume
40.3k
Shares, 9 Nov 2026

About Lotus Pharmaceuticals

Its shares trade under the ticker LTUS. It has been listed since 15 May 2012.

Lotus Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products in the People's Republic of China. The company is headquartered in Beijing, Beijing. The company went IPO on 2012-05-15. The firm produces crude medicine and drugs in forms of tablets, capsules, granules, eye-drops, and freeze-dried powder injection. Its drug development is focused on the treatment of cerebro-cardiovascular disease, asthma, and diabetes. The company operates, controls and owns the pharmaceutical businesses in China of Beijing Liang Fang Pharmaceutical Co., Ltd. (Liang Fang) and Beijing En Zhe Jia Shi Pharmaceutical Co., Ltd. (En Zhe Jia), collectively Lotus East. Lotus East is engaged in the production, trade and retailing of pharmaceuticals, focusing on the development of medicines and investing in strategic growth to address various medical needs. Lotus East owns and operates 10 drug stores throughout Beijing, China that sell Western and traditional Chinese medications, and generate revenues from the leasing of retail space to third party vendors in its retail stores.

Figures and description from our data supplier, not checked against the company's own report.

More about Lotus Pharmaceuticals →

Latest on Lotus Pharmaceuticals

Our reporting

We have not reported on Lotus Pharmaceuticals yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Lotus Pharmaceuticals's ticker?

Lotus Pharmaceuticals trades as LTUS on its US listing, under ISIN US5457152032.

What was Lotus Pharmaceuticals's last closing price?

0.00 on 9 Nov 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.